ABOUT US

ABOUT US

Ipsen is a global specialty-driven biotechnological group with total sales exceeding €1.2 billion in 2014. Ipsen sells more than 20 drugs in more than 115 countries, with a direct commercial presence in 30 countries. Ipsen’s ambition is to become a leader in specialty healthcare solutions for targeted debilitating diseases. Its development strategy is supported by 3 franchises: neurology, endocrinology and urology-oncology.

IPSEN AT A GLANCE

IPSEN AT A GLANCE

INNOVATION FOR PATIENT CARE

Ipsen focuses its resources and investments on three targeted specialty care areas, organized in Franchises.

READ MORE ❯

FLEX-IT

Drug treatment for spasticity and dystonia often have good effect, especially in combination with physical therapy / stretching exercises.

READ MORE ❯